HOME >> BIOLOGY >> NEWS
Green, leafy spinach may soon power cellphones and laptops

For the first time, MIT researchers have incorporated a plant's ability to convert sunlight to energy into a solid-state electronic "spinach sandwich" device that may one day power laptops and cell phones.

At the heart of the device is a protein complex dubbed Photosystem I (PSI). Derived from spinach chloroplasts, PSI is 10 to 20 nanometers wide. Around 100,000 of them would fit on the head of a pin. "They are the smallest electronic circuits I know of," said researcher Marc A. Baldo, assistant professor of electronic engineering and computer science at MIT.

Baldo and other researchers from MIT, the University of Tennessee and the U.S. Naval Research Laboratory, including electrical and biomedical engineers, nanotechnology experts and biologists, collaborated on the world's first solid-state photosynthetic solar cell. The work was reported in NanoLetters, a publication of the American Chemical Society.

"We have crossed the first hurdle of successfully integrating a photosynthetic protein molecular complex with a solid-state electronic device," Baldo said.

Plants' ability to generate energy has been optimized by evolution, so a spinach plant is extremely efficient, churning out a lot of energy relative to its size and weight. But combining biological and non-biological materials in one device has stymied researchers in the past. Biological materials need water and salt to survive-both are deadly for electronics.

FROM WET TO DRY

A new twist in the current work is a membrane of peptide surfactants-similar to the main ingredient in soap-that helped the photosynthetic complexes self-assemble and stabilize while the circuit was fabricated.

So far, scientists and engineers' efforts to harness the photosynthetic properties of green plants have been most successful with naturally soft organic materials in liquid solutions. But if organic solar cells are to be practical for commercial device
'"/>

Contact: Denise Brehm
brehm@mit.edu
617-253-2704
Massachusetts Institute of Technology
20-Sep-2004


Page: 1 2 3

Related biology news :

1. Green, black tea extracts found to lower cholesterol
2. New standard on the menu, certified slurried spinach
3. Making a safer anthrax vaccine using spinach
4. Wastewater could treat itself, power city
5. ASU researchers demonstrate new technique that improves the power of atomic force micrscopy
6. Coordinating power of circadian rhythms keeps estrus and pregnancy on track
7. FDA approves VYTORIN, first and only to powerfully reduce LDL cholesterol through dual inhibition
8. Spanish scientists develop powerful tool for exploration and integration of biological information
9. Volcanic soils yield new clues about the emergence of powerful chiefdoms in Hawaii
10. Motion that powers sperm provides key to unravelling rare genetic disorder
11. Ethanol to power the future of hydrogen fuel cells

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Green leafy spinach may soon power cellphones and laptops

(Date:12/17/2014)... -- Valencell, a leader in performance biometric data sensor ... leaders such as Intel, Jabra, Atlas, and Scosche to ... These products will be showcased at CES 2015, taking ... . "Our partners choose PerformTek biometrics, ... with the clinical data to back it up," said ...
(Date:12/11/2014)... Research and Markets , ... http://www.researchandmarkets.com/research/9ql3kr/biometrics_market ) has announced the addition of the ... to their offering. One major ... of multimodal biometric systems. Multimodal biometric systems utilize ... verification and identification purposes. This helps to reduce ...
(Date:12/10/2014)... Dec. 9, 2014  Wake Forest Baptist Medical Center today ... its School of Medicine. Funding for this $50 million ... that will be publicly launched next summer. ... the former 60 series R.J. Reynolds Tobacco Company complex, ... will begin immediately with plans to be ready to ...
Breaking Biology News(10 mins):Valencell PerformTek Biometrics Power the Most Accurate Wearables at CES 2015 2Biometrics Market in India 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 2Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 3Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 4
(Date:12/19/2014)... The empty capsules market is experiencing growth ... technological innovations in the empty capsules market. The ... growth of the empty capsules market. , Get ... of Report , The report will enrich both ... to gauge the pulse of the market which ...
(Date:12/19/2014)... YORK , Dec. 18, 2014 Relmada ... therapies for the treatment of chronic pain, announced the ... today. "This was a transformational year in ... promising future for our company," said Sergio Traversa ... year, we have executed on key financial, human resource ...
(Date:12/17/2014)... December 17, 2014 Ipsen Biopharmaceuticals, ... IPN; ADR: IPSEY), today announced that ... as Somatuline®) was approved by the U.S. Food ... gastroenteropancreatic neuroendocrine tumors (GEP-NETs) in adult patients with ... metastatic disease to improve progression-free survival (PFS). , ...
(Date:12/17/2014)... Audacity, a leading California-based health and science ... Huntsworth Health Group, is proud to announce the addition ... role, Gonzales will serve as Senior Vice President of ... welcome a talent of Jamie’s caliber to the Audacity ... is a proven healthcare innovation leader and brand management ...
Breaking Biology Technology:Empty Capsules Market Hit to Reach $1,820 Million by 2019 - New Research Report by MarketsandMarkets 2Empty Capsules Market Hit to Reach $1,820 Million by 2019 - New Research Report by MarketsandMarkets 3Empty Capsules Market Hit to Reach $1,820 Million by 2019 - New Research Report by MarketsandMarkets 4Relmada Therapeutics Announces Results of Annual Shareholders Meeting 2Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 2Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 3Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 4Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 5Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 6Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 7Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 8Audacity Welcomes Healthcare Communications Expert Jamie Gonzales as Senior Vice President of Client Services 2
Cached News: